This study was intended to compare the survival rates of two contemporary cohorts of patients with solitary hepatocellular carcinomas 5 4 cm subjected to surgical resection (n = 33) or percutaneous ethanol injection (n = 30). Outcomes in a third cohort, 21 patients with hepatocellular carcinoma who
Hepatic resection and percutaneous ethanol injection for the treatment of selected patients with more than one hepatocellular carcinoma
β Scribed by Giulio Belli; Antonio Iannelli; Giovanni Romano; Ines Marano
- Book ID
- 111738636
- Publisher
- Taylor and Francis Group
- Year
- 1999
- Weight
- 165 KB
- Volume
- 165
- Category
- Article
- ISSN
- 1102-4151
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: Percutaneous ethanol injection (pei) has been used in the far east for treating small, unresectable hepatocellular carcinoma (hcc). to clarify when treatment with pei may be best indicated for western patients with hcc, the authors performed a retrospective analysis of the clinicopat
This study was aimed at defining the therapeutic value of percutaneous ethanol injection in patients with solitary hepatocellular carcinoma less than 4 cm. Ultrasound-guided ethanol injection was performed in 24 cirrhotic patients (9 Child A, 10 Child B and 5 Child C), with hepatocellular carcinoma